• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Cough syrup's dangers debated

Article

Baltimore's commissioner of health Joshua Sharfstein, MD, led a group of 16 senior pediatricians to petition the FDA regarding over-the-counter cough and cold remedies.

Many such OTC drugs have not been accurately tested on children for proper dosage. Four Baltimore children under the age of 4 who died were linked to unintentional overdoes in the last few years, and such overdoses also led to 900 hospitalizations throughout Maryland.

FDA's Office of Nonprescription Products responded with a conference call saying the OTC products were currently under investigation, with possible new dosage labeling to come. A statement from the Consumer Healthcare Products Association emphasized that, despite pictures of babies on the boxes, all such OTC drugs also say to contact a doctor for dosage instructions for children under 2.

Related Videos
Natasha Hoyte, MPH, CPNP-PC
Lauren Flagg
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Ashley Gyura, DNP, CPNP-PC | Image Credit: Children's Minnesota
Congenital heart disease and associated genetic red flags
Traci Gonzales, MSN, APRN, CPNP-PC
© 2024 MJH Life Sciences

All rights reserved.